Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Increase in cerebral blood flow describes a physiological state or functional response wherein the volume of blood passing through brain tissue per unit time is elevated. This phenomenon can result from physiological processes (e.g., increased neuronal activity via neurovascular coupling), pharmacologic intervention (e.g., vasodilators), or pathologic states (e.g., hypercapnia-induced vasodilation or autoregulatory breakthrough in hypertension). Regulation of cerebral blood flow is multifactorial, involving arteriolar smooth muscle tone, neural and metabolic signaling, endothelial mediators (nitric oxide, eicosanoids, endothelins), and auto-regulatory responses to perfusion pressure, but no single receptor, enzyme, or protein is solely responsible for the process[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Increase in cerebral blood flow.